Correction to: Communications Biology https://doi.org/10.1038/s42003-022-03805-y, published online 26 August 2022.
The original version of this Article was missing several references in the following paragraph in the Introduction:
“In addition to MOG, MCT2 transports endogenous monocarboxylates ranging from pyruvate and lactate to larger ketone bodies such as β-hydroxybutyrate, acetoacetate, α-ketoisovalerate and α-ketoisocaproate19 (Supplementary Fig. 1a) with a higher affinity than the other SLC16 family members9. MCT2 plays important physiological roles including the uptake of astrocyte-secreted lactate into neurons within the brain. MCT2 is highly expressed in some human cancers (Supplementary Fig. 1b) and has been proposed as a biomarker for prostate cancer, as well as having pro-tumorigenic and pro-metastatic roles in breast cancer.”
The correct version of this paragraph should appear as:
“In addition to MOG, MCT2 transports endogenous monocarboxylates ranging from pyruvate and lactate to larger ketone bodies such as β-hydroxybutyrate, acetoacetate, α-ketoisovalerate and α-ketoisocaproate19 (Supplementary Fig. 1a) with a higher affinity than the other SLC16 family members9. MCT2 plays important physiological roles including the uptake of astrocyte-secreted lactate into neurons within the brain20-21. MCT2 is highly expressed in some human cancers (Supplementary Fig. 1b) and has been proposed as a biomarker for prostate cancer22, as well as having pro-tumorigenic23 and pro-metastatic24 roles in breast cancer.”
References #20-24 were mistakenly cited in the following sentence in the Introduction:
“Here, we report the design and synthesis of MOG-based analogues and use them to explore the MCT2 pharmacophore, and [NOG]IC-dependent interference with intracellular targets in the context of their effects on cellular proliferation and survival20-24.”
The correct version of this sentence should appear as:
“Here, we report the design and synthesis of MOG-based analogues and use them to explore the MCT2 pharmacophore, and [NOG]IC-dependent interference with intracellular targets in the context of their effects on cellular proliferation and survival.”
Both errors have now been corrected in the PDF and HTML versions of the Article.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Fets, L., Bevan, N., Nunes, P.M. et al. Publisher Correction: MOG analogues to explore the MCT2 pharmacophore, α-ketoglutarate biology and cellular effects of N-oxalylglycine. Commun Biol 5, 1019 (2022). https://doi.org/10.1038/s42003-022-03922-8
Published:
DOI: https://doi.org/10.1038/s42003-022-03922-8
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.